首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   244篇
  免费   20篇
耳鼻咽喉   2篇
儿科学   6篇
妇产科学   4篇
基础医学   50篇
口腔科学   1篇
临床医学   22篇
内科学   56篇
皮肤病学   2篇
神经病学   34篇
特种医学   3篇
外科学   19篇
综合类   1篇
一般理论   1篇
预防医学   15篇
眼科学   1篇
药学   15篇
中国医学   2篇
肿瘤学   30篇
  2023年   2篇
  2021年   4篇
  2020年   7篇
  2019年   3篇
  2018年   18篇
  2017年   12篇
  2016年   5篇
  2015年   8篇
  2014年   5篇
  2013年   9篇
  2012年   25篇
  2011年   26篇
  2010年   8篇
  2009年   5篇
  2008年   14篇
  2007年   15篇
  2006年   13篇
  2005年   15篇
  2004年   11篇
  2003年   7篇
  2002年   10篇
  2001年   1篇
  1999年   2篇
  1998年   2篇
  1997年   3篇
  1996年   1篇
  1995年   1篇
  1992年   3篇
  1991年   1篇
  1990年   4篇
  1989年   2篇
  1987年   2篇
  1986年   2篇
  1985年   1篇
  1984年   2篇
  1981年   2篇
  1980年   1篇
  1979年   3篇
  1978年   1篇
  1977年   1篇
  1974年   1篇
  1971年   2篇
  1965年   1篇
  1935年   2篇
  1933年   1篇
排序方式: 共有264条查询结果,搜索用时 31 毫秒
41.
42.
43.
44.
45.
46.
BackgroundFabry disease is characterized by accumulation of glycosphingolipids, such as globotriaosylceramide (Gb3), in many tissues and body fluids. A novel plasma biomarker, globotriaosylsphingosine (lyso-Gb3), is increased in patients with the disease. Until now, lyso-Gb3 was not detectable in urine, possibly because of the presence of interfering compounds.MethodsWe undertook to: 1) characterize lyso-Gb3 in urine; 2) develop a method to quantitate urinary lyso-Gb3 by mass spectrometry; 3) evaluate urinary lyso-Gb3 as a potential biomarker for Fabry disease; and 4) determine whether lyso-Gb3 is an inhibitor of α-galactosidase A activity. We analyzed urinary lyso-Gb3 from 83 Fabry patients and 77 healthy age-matched controls.ResultsThe intraday and interday bias and precision of the method were < 15%. Increases in lyso-Gb3/creatinine correlated with the concentrations of Gb3 (r2 = 0.43), type of mutations (p = 0.0006), gender (p < 0.0001) and enzyme replacement therapy status (p = 0.0012). Urine from healthy controls contained no detectable lyso-Gb3. Lyso-Gb3 did not inhibit GLA activity in dried blood spots. Increased urinary excretion of lyso-Gb3 of Fabry patients correlated well with a number of indicators of disease severity.ConclusionLyso-Gb3 is a reliable independent biomarker for clinically important characteristics of Fabry disease.  相似文献   
47.
48.
Summary A retrospective review of a series of 71 patients operated on between January 1986 and December 1995, for bilateral inguinal hernias was carried out. The patients were treated by insertion of a non-absorbable unslit mesh via either the inguinal route or a laparoscopic approach. A two stage operation via the inguinal route was performed in 23 patients (group A). The remainder underwent a one-stage procedure: 23 patients (group B) were offered open repair using a preperitoneal mesh via a bilateral inguinal route and 25 patients (group C) underwent bilateral laparoscopic repair through a totally preperitoneal approach (n=is) or a transperitoneal approach (n=10). The three groups were broadly similar and comparable. The length of operative procedure was identical in the 3 groups. The duration of hospital stay was respectively 11.2, 5.8 and 3.3 days in the three groups. The return to normal activities was shorter in groups B and C than in group A. At long term, with a mean follow-up of two years, the rate of recurrence was similar in the 3 groups. This study confirmed that a one stage operation does not carry great risks, and has the advantages of sparing the patient a second operation. It is economical in terms of operating time, duration of hospital stay, and delay in return to work. The laparoscopic procedure seems the most suitable approach for these hernia repairs. Further investigation of this technique in comparison with other open herniorrhaphy procedures, with randomised prospective trials, is required before its widescale application can be recommended.  相似文献   
49.
50.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号